Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
Where this comes from
- Record sourced from PubMed, PMID 32255489.
- Also identified by DOI 10.1093/cid/ciaa394 and PMC identifier 7184449.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting in various concentrations. Pharmacokinetic studies are therefore needed to define the optimal dosing regimen.
Medical subject headings
- Hydroxychloroquine
- COVID-19 Drug Treatment